Zentalis Pharmaceuticals
Biotechnology ResearchNew York, United States51-200 Employees
Developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer
Insights
Key Personnel Change Zentalis Pharmaceuticals has recently appointed accomplished oncology drug developer Luke Walker, M.D., to its Board of Directors, presenting an opportunity for sales professionals to engage with new leadership and potentially explore collaborations or partnerships.
Expansion in Leadership Team The expansion of Zentalis Pharmaceuticals' leadership team with appointments like Kyle Rasbach as Chief Business Officer and Diana Hausman as Chief Medical Officer and Chief Business Officer opens up avenues for sales professionals to pitch their products or services that complement the strategic direction set by these key executives.
Departure of Senior Vice President The departure of Dr. Voliotis, Senior Vice President & Head of Global Development, from Zentalis Pharmaceuticals creates an opportunity for sales development representatives to engage with the new leadership and potentially offer solutions to fill the gap left by the departing executive.
Appointment of Chief Strategy Officer The appointment of Kimberly Freeman as Chief Strategy Officer at Zentalis Pharmaceuticals signals a focus on strategic growth initiatives, providing sales professionals with an opportunity to align their offerings with the company's evolving strategies and priorities.
Strategic Hiring in Medicine Development Zentalis Pharmaceuticals' strategic hiring of Iris Roth as Vice President, Medicine Development Leader, highlights a focus on advancing clinical differentiation in small molecule therapeutics, presenting a potential sales opportunity for companies offering complementary technologies or services in this domain.
Zentalis Pharmaceuticals Tech Stack
Zentalis Pharmaceuticals uses 8 technology products and services including jQuery CDN, WordPress, NetSuite, and more. Explore Zentalis Pharmaceuticals's tech stack below.
- jQuery CDNContent Delivery Network
- WordPressContent Management System
- NetSuiteE-commerce
- ModernizrJavascript Libraries
- Microsoft AzurePlatform As A Service
- PerlProgramming Languages
- PHPProgramming Languages
- Akamai Bot ManagerSecurity
Media & News
Zentalis Pharmaceuticals's Email Address Formats
Zentalis Pharmaceuticals uses at least 1 format(s):
| Zentalis Pharmaceuticals Email Formats | Percentage |
| FLast@zentalis.com | 96% |
| First@zentalis.com | 1% |
| First.Last@zentalis.com | 2% |
| Last@zentalis.com | 1% |
Frequently Asked Questions
Where is Zentalis Pharmaceuticals's headquarters located?
Zentalis Pharmaceuticals's main headquarters is located at 530 Seventh Avenue Suite 2201 New York, NY 10018 US. The company has employees across 4 continents, including North AmericaAsiaEurope. What is Zentalis Pharmaceuticals's stock symbol?
Zentalis Pharmaceuticals is a publicly traded company; the company's stock symbol is ZNTL. What is Zentalis Pharmaceuticals's official website and social media links?
Zentalis Pharmaceuticals's official website is zentalis.com and has social profiles on LinkedIn.How much revenue does Zentalis Pharmaceuticals generate?
As of October 2024, Zentalis Pharmaceuticals's annual revenue reached $15M. What is Zentalis Pharmaceuticals's SIC code NAICS code?
Zentalis Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Zentalis Pharmaceuticals have currently?
As of October 2024, Zentalis Pharmaceuticals has approximately 167 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: K. B.Chief Marketing Officer: R. E. W.Chief Strategy Officer: K. F.. Explore Zentalis Pharmaceuticals's employee directory with LeadIQ.What industry does Zentalis Pharmaceuticals belong to?
Zentalis Pharmaceuticals operates in the Biotechnology Research industry. What technology does Zentalis Pharmaceuticals use?
Zentalis Pharmaceuticals's tech stack includes jQuery CDNWordPressNetSuiteModernizrMicrosoft AzurePerlPHPAkamai Bot Manager. What is Zentalis Pharmaceuticals's email format?
Zentalis Pharmaceuticals's email format typically follows the pattern of . Find more Zentalis Pharmaceuticals email formats with LeadIQ. How much funding has Zentalis Pharmaceuticals raised to date?
As of October 2024, Zentalis Pharmaceuticals has raised $236M in funding. The last funding round occurred on Jun 15, 2023 for $236M.
Company Overview
- Headquarters
- 530 Seventh Avenue Suite 2201 New York, NY 10018 US
- Website
- zentalis.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- ZNTL
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 51-200
Media & News
Funding & Financials
- $236M
Zentalis Pharmaceuticals has raised a total of $236M of funding over 7 rounds. Their latest funding round was raised on Jun 15, 2023 in the amount of $236M.
- $10M$50M
Zentalis Pharmaceuticals's revenue is in the range of $10M$50M
Funding & Financials
- $236M
Zentalis Pharmaceuticals has raised a total of $236M of funding over 7 rounds. Their latest funding round was raised on Jun 15, 2023 in the amount of $236M.
- $10M$50M
Zentalis Pharmaceuticals's revenue is in the range of $10M$50M
Company Leadership
K. B.Chief Executive Officer- R. E. W.Chief Marketing Officer
- K. F.Chief Strategy Officer
K. R.Chief Business Officer- A. P.Chief Legal Officer And Corporate Secretary
Employee Directory
- C. G.Co-Founder, President & Board Member
D. J.Board Member - Chairman- K. B.Chief Executive Officer
- A. A. S.Co-Founder & Consultant
- C. S.Executive Business Partner - Office Of The Cfo And Cso
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
